Clinical Trials Logo

Clinical Trial Summary

Genetic polymorphism on the effect of oral caffeine intake on fat oxidation during exercise has been studied in active and healthy population performing an incremental test on a cycle ergometer with 3-min stages at workloads from 30 to 70% of maximal oxygen uptake (VO2max). Participants performed this test after the ingestion of a) placebo; b) 3 mg/kg of caffeine; c) 6 mg/kg of caffeine. Fat oxidation rate during exercise was measured by indirect calorimetry. The influence of the CYP1A2 c.-163A>C, GSTP c.313A>G and PGC1a polymorphisms was evaluated to determine the effects on fat oxidation during exercise


Clinical Trial Description

Caffeine is a natural stimulant with well-recognized sports performance benefits. Aside its performance-enhancing effect, caffeine has the potential of increasing fat utilization during aerobic exercise at submaximal intensities, lowering-down the contribution of carbohydrate as a fuel. This property of caffeine may provoke a glycogen-sparing effect in the skeletal muscle and liver for exercise situations where carbohydrate availability may be a challenge. Additionally, the capacity of caffeine to enhance fat utilization during exercise could be of interest for improving health outcomes as it may increase the rate of change in body composition in exercise programs. Genetic factors like CYP1A2 c.-163A>C, GSTP c.313A>G and PGC1a c.1444G>A and C>T polymorphisms could be associated with the capacity for fat oxidation during exercise. To date, it is unknown if genetics increases fat oxidation and MFO in the same proportion during morning and evening exercise trials in women. For this reason, the aim of the present study was to evaluate the influence of the tCYP1A2, GSTP and PGC1a polymorphisms on the effect of caffeine on fat oxidation and MFO in active and healthy population. The authors hypothesised that genetics would increase fat oxidation and MFO during exercise and this effect would be of similar magnitude at several caffeine doses. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05975489
Study type Interventional
Source Universidad Francisco de Vitoria
Contact
Status Completed
Phase N/A
Start date October 1, 2020
Completion date April 1, 2022

See also
  Status Clinical Trial Phase
Completed NCT06038903 - The Turkish Version Of The Brief-Caffeine Expectancy Questionnaire
Completed NCT02900261 - Study on Sodium and Caffeine in Children and Adolescents
Completed NCT03850275 - The Effects of e+Shots Energy Beverage on Mental Energy N/A
Completed NCT01924481 - Effects of a Cocoa Shot on the Human Brain N/A
Completed NCT01330680 - Genetic Determinants of Cardiovascular Response to Coffee Drinking N/A
Completed NCT00184912 - The Effect of Caffeine on Ischemic Preconditioning N/A
Completed NCT03859882 - Protocol PERCAF 2018 N/A
Completed NCT02832401 - The Impact of Caffeine on Cognition in Schizophrenia N/A
Completed NCT04560595 - Remote Guided Caffeine Reduction N/A
Recruiting NCT05503732 - Effects of Energy Drinks on Sleep and Cardiovascular Health N/A
Not yet recruiting NCT05521386 - The Effects of Caffeine on Heart Rate and Heart Rate Variability N/A
Completed NCT06039358 - Effects of Caffeine Ingestion on the Biomechanics of Healthy Young Subjects N/A
Active, not recruiting NCT04547868 - Can Coffee/Caffeine Improve Post-Operative Gastrointestinal Recovery N/A
Completed NCT05559372 - Energy Drink Effects on Performance, Mood, and Cardiovascular Outcomes N/A
Completed NCT01783561 - Early Versus Routine Caffeine Administration in Extremely Preterm Neonates Phase 4
Completed NCT04852315 - Acute Caffeine Ingestion on Futsal Performance N/A
Recruiting NCT03298347 - Caffeine for Preterm Infants With Apnea of Prematurity(AOP) N/A
Completed NCT01435486 - Caffeine Citrate for the Treatment of Apnea Associated With Bronchiolitis in Young Infants N/A
Completed NCT04869176 - Effect of Caffeine on Heart Rate Variability in Newborns N/A
Completed NCT04585854 - Effect of Caffeine on Myocardial Oxygenation N/A